Doctors at the Oklahoma Medical Research Foundation are celebrating what could become a breakthrough in brain cancer treatment.
Despite its reputation as a disease that strikes in later years, colon cancer affects people of all ages.
The drug treats fast-growing, deadly brain cancers with no effective treatment.
A recent discovery by scientists at OMRF could aid in the development of potential therapies for lymphedema.
Cancer remains a daunting foe. But the odds of surviving this terrible disease should continue to improve.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.